Cambridge, UK, 22nd May 2023 – PharmEnable, a drug discovery company focused on chemical novelty, diversity and complexity, announces it has closed a Pre-Series A investment round of $7.5M to develop the next generation of small molecule Read More
Tags :Wren Capital
BIRMINGHAM, UK – April 6, 2022 – Biomedical startup Adapttech today announced that it has raised £2.25M from investors including Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club. The company also announced the launch of the new Read More
Digital brain biomarker company Monument Therapeutics raises £2.6 million Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction Manchester, UK, August 2021: Monument Therapeutics, a stratified medicine company, has raised £2.625 million in seed funding to spin Read More
ADAPTTECH SECURES £2 MILLION IN NEW FUNDING Biomedical company will use funding to develop new technologies and grow sales of next generation system for improving the fitting of prosthetic devices. BIRMINGHAM, UK – MARCH 23, 2021 – Biomedical startup&Read More
Antiverse raises £1.4 million ($2 million USD) to advance its AI antibody drug discovery platform · Funding will accelerate development of the Company’s AI-powered antibody drug discovery technology, Read More
FUNDING THE FUTURE OF PEST CONTROL Spotta’s smart pest systems attracts $1.18 million in seed funding EMBARGOED UNTIL 28 JULY 2020, 6AM BST: Investors have rewarded the commercial success of Spotta’s smart pest systems with a $1.18 Read More
Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion £1.8m seed financing led by Cambridge Enterprise alongside angel investors and life science investment funds Using advanced medicinal chemistry and AI approaches to develop highly complex Read More